Article

Effectively Combating Antimicrobial Resistance: Assessing the Clinical Outcomes of Antimicrobial Stewardship Intervention in Patients with Critical Priority Pathogens

Tarun Singh1, Sumeet Gupta1, Anuj Malik1★, Chakrant Mothsara2, Avaneesh Pandey3, Narinder Kaur4, Bimal K. Agrawal4★ Corresponding author

  1. 1MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, INDIA.
  2. 2Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, INDIA.
  3. 3ICMR-PGIMER Advanced Center for Product Development, Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, INDIA.
  4. 4MM Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, INDIA.

CORRESPONDENCE

Anuj Malik

MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, INDIA.

doctarunmmu@gmail.com

Received: 01-11-2024; Revised: 15-11-2024; Accepted: 02-12-2024.

Volume 16, Issue 1 · pp. 50–57 · PUBLISHED · DOI: 10.5530/jyp.2024.16.7

View on JYP original site ↗

ABSTRACT

Background: Amid the pressing global concern of Antimicrobial Resistance (AMR), where Antimicrobial Stewardship (AMS) stands as a promising solution in relation to this, critical priority has been assigned to AMR pathogens in the Indian Pathogen Priority List to steer research focused on antibiotic-resistant bacteria. The study's particular objective is to assess how an AMS intervention affects these pathogens in adult patients. Materials and Methods:Over a dedicated two-year period from January 2021 to November 2022 research focused on adult patients harboring critical priority pathogens, adhering to ICMR directives. The primary goal was to comprehend antimicrobial drug usage in hospital's medicine and surgery unit. Employing a qualitative approach, study conducted a Prospective Audit with Feedback (PAF), implementing deliberate constraints on antimicrobial drug usage to gain insights. Results: The analysis encompassed 314 participants: 96 in control phase, and 115 and 103 in the intervention phases 2 and 3. Comparable demographics and service scope existed between intervention and control groups. All arms exhibited the presence of culture-positive organisms from the critical priority pathogen list defined by ICMR. Impressively, length of therapy per 1000 patient days notably dropped from 908.50 to 758.33 (p=0.001) post-intervention. Conclusion: The study's conclusion highlights responsible antimicrobial use in a tertiary care setting, showcasing promising progress. Noteworthy impacts on the dependent variable (Log_LOT) emerged across study phases, emphasizing intervention significance. Statistically significant Ward and Phase variables further enriched the overall insights.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Singh, T., Gupta, S., Malik, A., Mothsara, C., Pandey, A., Kaur, N., & Agrawal, B. K. (). Effectively Combating Antimicrobial Resistance: Assessing the Clinical Outcomes of Antimicrobial Stewardship Intervention in Patients with Critical Priority Pathogens. Journal of Young Pharmacists, 16(1), 50–57. https://doi.org/10.5530/jyp.2024.16.7